0 XP   0   0   0

Divi's Laboratories Limited
Buy, Hold or Sell?

Should you buy, hold or sell Divi's Laboratories Limited?

I guess you are interested in Divi's Laboratories Limited. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Divi's Laboratories Limited

Let's start. I'm going to help you getting a better view of Divi's Laboratories Limited. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Divi's Laboratories Limited even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Divi's Laboratories Limited is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Divi's Laboratories Limited. The closing price on 2023-01-27 was INR3,386 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Divi's Laboratories Limited Daily Candlestick Chart
Divi's Laboratories Limited Daily Candlestick Chart
Summary









1. Valuation of Divi's Laboratories Limited




Current price per share

INR3,385.55

2. Growth of Divi's Laboratories Limited




Is Divi's Laboratories Limited growing?

Current yearPrevious yearGrowGrow %
How rich?$1.4b$1.1b$299.3m20.7%

How much money is Divi's Laboratories Limited making?

Current yearPrevious yearGrowGrow %
Making money$364.1m$244m$120m33.0%
Net Profit Margin33.0%28.5%--

How much money comes from the company's main activities?

3. Financial Health of Divi's Laboratories Limited




Comparing to competitors in the Other industry




  Industry Rankings (Other)  


Richest
#65 / 441

Most Revenue
#48 / 441

Most Profit
#9 / 441


Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is very efficient in making profit.
Using its investors money, the company is very efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is very efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of Divi's Laboratories Limited.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Divi's Laboratories Limited earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare Divi's Laboratories Limited to the Other industry mean.
  • A Net Profit Margin of 33.0% means that ₹0.33 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Divi's Laboratories Limited:

  • The MRQ is 33.0%. The company is making a huge profit. +2
  • The TTM is 33.0%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ33.0%TTM33.0%0.0%
TTM33.0%YOY28.5%+4.6%
TTM33.0%5Y27.4%+5.7%
5Y27.4%10Y27.8%-0.4%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ33.0%8.2%+24.8%
TTM33.0%7.4%+25.6%
YOY28.5%7.3%+21.2%
5Y27.4%6.7%+20.7%
10Y27.8%6.6%+21.2%
1.1.2. Return on Assets

Shows how efficient Divi's Laboratories Limited is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Divi's Laboratories Limited to the Other industry mean.
  • 22.1% Return on Assets means that Divi's Laboratories Limited generated ₹0.22 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Divi's Laboratories Limited:

  • The MRQ is 22.1%. Using its assets, the company is very efficient in making profit. +2
  • The TTM is 22.1%. Using its assets, the company is very efficient in making profit. +2
Trends
Current periodCompared to+/- 
MRQ22.1%TTM22.1%0.0%
TTM22.1%YOY18.4%+3.7%
TTM22.1%5Y17.3%+4.8%
5Y17.3%10Y18.5%-1.2%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ22.1%1.0%+21.1%
TTM22.1%1.0%+21.1%
YOY18.4%0.9%+17.5%
5Y17.3%0.9%+16.4%
10Y18.5%0.9%+17.6%
1.1.3. Return on Equity

Shows how efficient Divi's Laboratories Limited is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Divi's Laboratories Limited to the Other industry mean.
  • 25.2% Return on Equity means Divi's Laboratories Limited generated ₹0.25 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Divi's Laboratories Limited:

  • The MRQ is 25.2%. Using its investors money, the company is very efficient in making profit. +2
  • The TTM is 25.2%. Using its investors money, the company is very efficient in making profit. +2
Trends
Current periodCompared to+/- 
MRQ25.2%TTM25.2%0.0%
TTM25.2%YOY21.3%+3.9%
TTM25.2%5Y19.9%+5.3%
5Y19.9%10Y21.8%-1.9%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ25.2%3.1%+22.1%
TTM25.2%2.9%+22.3%
YOY21.3%2.6%+18.7%
5Y19.9%2.4%+17.5%
10Y21.8%2.4%+19.4%

1.2. Operating Efficiency of Divi's Laboratories Limited.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Divi's Laboratories Limited is operating .

  • Measures how much profit Divi's Laboratories Limited makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Divi's Laboratories Limited to the Other industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Divi's Laboratories Limited:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y22.7%-22.7%
5Y22.7%10Y27.9%-5.2%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ-17.1%-17.1%
TTM-9.1%-9.1%
YOY-9.2%-9.2%
5Y22.7%8.5%+14.2%
10Y27.9%8.5%+19.4%
1.2.2. Operating Ratio

Measures how efficient Divi's Laboratories Limited is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Other industry mean).
  • An Operation Ratio of 0.39 means that the operating costs are ₹0.39 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of Divi's Laboratories Limited:

  • The MRQ is 0.389. The company is very efficient in keeping operating costs low. +2
  • The TTM is 0.389. The company is very efficient in keeping operating costs low. +2
Trends
Current periodCompared to+/- 
MRQ0.389TTM0.3890.000
TTM0.389YOY0.395-0.005
TTM0.3895Y0.828-0.439
5Y0.82810Y0.948-0.120
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3891.218-0.829
TTM0.3891.189-0.800
YOY0.3951.203-0.808
5Y0.8281.289-0.461
10Y0.9481.314-0.366

1.3. Liquidity of Divi's Laboratories Limited.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Divi's Laboratories Limited is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Other industry mean).
  • A Current Ratio of 6.99 means the company has ₹6.99 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of Divi's Laboratories Limited:

  • The MRQ is 6.985. The company is very able to pay all its short-term debts. +2
  • The TTM is 6.985. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ6.985TTM6.9850.000
TTM6.985YOY5.551+1.435
TTM6.9855Y6.004+0.982
5Y6.00410Y5.455+0.548
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ6.9851.491+5.494
TTM6.9851.465+5.520
YOY5.5511.475+4.076
5Y6.0041.299+4.705
10Y5.4551.286+4.169
1.3.2. Quick Ratio

Measures if Divi's Laboratories Limited is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Divi's Laboratories Limited to the Other industry mean.
  • A Quick Ratio of 3.04 means the company can pay off ₹3.04 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Divi's Laboratories Limited:

  • The MRQ is 3.043. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 3.043. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.043TTM3.0430.000
TTM3.043YOY3.332-0.289
TTM3.0435Y4.475-1.431
5Y4.47510Y3.821+0.653
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ3.0430.612+2.431
TTM3.0430.602+2.441
YOY3.3320.600+2.732
5Y4.4750.563+3.912
10Y3.8210.552+3.269

1.4. Solvency of Divi's Laboratories Limited.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Divi's Laboratories Limited assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Divi's Laboratories Limited to Other industry mean.
  • A Debt to Asset Ratio of 0.12 means that Divi's Laboratories Limited assets are financed with 12.3% credit (debt) and the remaining percentage (100% - 12.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Divi's Laboratories Limited:

  • The MRQ is 0.123. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.123. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.123TTM0.1230.000
TTM0.123YOY0.137-0.014
TTM0.1235Y0.133-0.010
5Y0.13310Y0.148-0.015
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1230.562-0.439
TTM0.1230.583-0.460
YOY0.1370.586-0.449
5Y0.1330.583-0.450
10Y0.1480.576-0.428
1.4.2. Debt to Equity Ratio

Measures if Divi's Laboratories Limited is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Divi's Laboratories Limited to the Other industry mean.
  • A Debt to Equity ratio of 14.0% means that company has ₹0.14 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Divi's Laboratories Limited:

  • The MRQ is 0.140. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.140. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.140TTM0.1400.000
TTM0.140YOY0.159-0.019
TTM0.1405Y0.154-0.013
5Y0.15410Y0.175-0.021
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1401.244-1.104
TTM0.1401.337-1.197
YOY0.1591.370-1.211
5Y0.1541.439-1.285
10Y0.1751.455-1.280

2. Market Valuation of Divi's Laboratories Limited

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings Divi's Laboratories Limited generates.

  • Above 15 is considered overpriced but always compare Divi's Laboratories Limited to the Other industry mean.
  • A PE ratio of 39.49 means the investor is paying ₹39.49 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Divi's Laboratories Limited:

  • The EOD is 30.359. Good. +1
  • The MRQ is 39.490. Good. +1
  • The TTM is 39.490. Good. +1
Trends
Current periodCompared to+/- 
EOD30.359MRQ39.490-9.131
MRQ39.490TTM39.4900.000
TTM39.490YOY48.565-9.075
TTM39.4905Y38.558+0.932
5Y38.55810Y37.161+1.397
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
EOD30.35936.308-5.949
MRQ39.49038.458+1.032
TTM39.49044.588-5.098
YOY48.56548.072+0.493
5Y38.55840.090-1.532
10Y37.16141.443-4.282
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Divi's Laboratories Limited.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of Divi's Laboratories Limited:

  • The MRQ is 26.469. Seems overpriced? -1
  • The TTM is 26.469. Seems overpriced? -1
Trends
Current periodCompared to+/- 
MRQ26.469TTM26.4690.000
TTM26.469YOY33.690-7.221
TTM26.4695Y31.874-5.406
5Y31.87410Y30.527+1.348
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ26.4690.154+26.315
TTM26.4690.050+26.419
YOY33.6900.186+33.504
5Y31.8740.158+31.716
10Y30.5270.155+30.372

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Divi's Laboratories Limited is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Other industry mean).
  • A PB ratio of 9.97 means the investor is paying ₹9.97 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of Divi's Laboratories Limited:

  • The EOD is 7.663. Seems overpriced? -1
  • The MRQ is 9.968. Seems overpriced? -1
  • The TTM is 9.968. Seems overpriced? -1
Trends
Current periodCompared to+/- 
EOD7.663MRQ9.968-2.305
MRQ9.968TTM9.9680.000
TTM9.968YOY10.368-0.400
TTM9.9685Y7.787+2.181
5Y7.78710Y8.220-0.433
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
EOD7.6631.411+6.252
MRQ9.9681.419+8.549
TTM9.9681.575+8.393
YOY10.3681.352+9.016
5Y7.7871.288+6.499
10Y8.2201.330+6.890
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Divi's Laboratories Limited compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--91.67191.6710%74.762+23%47.996+91%49.088+87%
Book Value Growth--1.2621.2620%1.272-1%1.173+8%1.190+6%
Book Value Per Share--441.791441.7910%350.120+26%310.505+42%239.928+84%
Book Value Per Share Growth--1.2621.2620%1.272-1%1.173+8%1.190+6%
Current Ratio--6.9856.9850%5.551+26%6.004+16%5.455+28%
Debt To Asset Ratio--0.1230.1230%0.137-10%0.133-7%0.148-17%
Debt To Equity Ratio--0.1400.1400%0.159-12%0.154-9%0.175-20%
Dividend Per Share--20.00020.0000%-+100%16.532+21%14.134+42%
Eps--111.518111.5180%74.747+49%64.422+73%51.741+116%
Eps Growth--1.4921.4920%1.442+3%1.264+18%1.211+23%
Free Cash Flow Per Share--45.15045.1500%39.053+16%22.536+100%21.917+106%
Free Cash Flow Per Share Growth--1.1561.1560%31.676-96%6.814-83%4.773-76%
Free Cash Flow To Equity Per Share--25.09425.0940%37.739-34%5.819+331%7.691+226%
Free Cash Flow To Equity Per Share Growth--0.6650.6650%2.946-77%-7.425+1217%4.631-86%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--951.687--------
Intrinsic Value_10Y_min--799.334--------
Intrinsic Value_1Y_max--56.102--------
Intrinsic Value_1Y_min--54.515--------
Intrinsic Value_3Y_max--198.488--------
Intrinsic Value_3Y_min--186.924--------
Intrinsic Value_5Y_max--376.951--------
Intrinsic Value_5Y_min--343.667--------
Net Profit Margin--0.3300.3300%0.285+16%0.274+21%0.278+19%
Operating Margin----0%-0%0.227-100%0.279-100%
Operating Ratio--0.3890.3890%0.395-1%0.828-53%0.948-59%
Pb Ratio7.663-30%9.9689.9680%10.368-4%7.787+28%8.220+21%
Pe Ratio30.359-30%39.49039.4900%48.565-19%38.558+2%37.161+6%
Peg Ratio--26.46926.4690%33.690-21%31.874-17%30.527-13%
Price Per Share3385.550-30%4403.8504403.8500%3630.050+21%2562.830+72%1953.611+125%
Price To Total Gains Ratio30.317-30%39.43639.4360%48.555-19%38.473+3%32.656+21%
Profit Growth--1.4921.4920%1.442+3%1.264+18%1.211+23%
Quick Ratio--3.0433.0430%3.332-9%4.475-32%3.821-20%
Return On Assets--0.2210.2210%0.184+20%0.173+28%0.185+19%
Return On Equity--0.2520.2520%0.213+18%0.199+27%0.218+16%
Revenue Growth--1.2861.2860%1.2920%1.177+9%1.177+9%
Total Gains Per Share--111.671111.6710%74.762+49%64.528+73%63.222+77%
Total Gains Per Share Growth--1.4941.4940%1.441+4%1.262+18%1.128+32%
Usd Book Value--1442566140.0001442566140.0000%1143237030.000+26%1013880636.000+42%783428926.600+84%
Usd Book Value Change Per Share--1.1281.1280%0.920+23%0.590+91%0.604+87%
Usd Book Value Per Share--5.4345.4340%4.306+26%3.819+42%2.951+84%
Usd Dividend Per Share--0.2460.2460%-+100%0.203+21%0.174+42%
Usd Eps--1.3721.3720%0.919+49%0.792+73%0.636+116%
Usd Free Cash Flow----0%-0%-0%-0%
Usd Free Cash Flow Per Share--0.5550.5550%0.480+16%0.277+100%0.270+106%
Usd Free Cash Flow To Equity Per Share--0.3090.3090%0.464-34%0.072+331%0.095+226%
Usd Price Per Share41.642-30%54.16754.1670%44.650+21%31.523+72%24.029+125%
Usd Profit--364135350.000364135350.0000%244067670.000+49%210355338.000+73%168948597.500+116%
Usd Revenue--1102059090.0001102059090.0000%857236200.000+29%742494174.000+48%597580737.267+84%
Usd Total Gains Per Share--1.3741.3740%0.920+49%0.794+73%0.778+77%
 EOD+3 -2MRQTTM+0 -0YOY+29 -105Y+34 -610Y+33 -7

3.2. Fundamental Score

Let's check the fundamental score of Divi's Laboratories Limited based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1530.359
Price to Book Ratio (EOD)Between0-17.663
Net Profit Margin (MRQ)Greater than00.330
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than13.043
Current Ratio (MRQ)Greater than16.985
Debt to Asset Ratio (MRQ)Less than10.123
Debt to Equity Ratio (MRQ)Less than10.140
Return on Equity (MRQ)Greater than0.150.252
Return on Assets (MRQ)Greater than0.050.221
Total7/10 (70.0%)

3.3. Technical Score

Let's check the technical score of Divi's Laboratories Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose3,389.800
Total1/1 (100.0%)



Latest Balance Sheet

Balance Sheet of 2022-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets133,747,100
Total Liabilities16,465,300
Total Stockholder Equity117,281,800
 As reported
Total Liabilities 16,465,300
Total Stockholder Equity+ 117,281,800
Total Assets = 133,747,100

Assets

Total Assets133,747,100
Total Current Assets83,515,000
Long-term Assets83,515,000
Total Current Assets
Cash And Cash Equivalents 218,800
Net Receivables 24,238,800
Inventory 29,159,300
Other Current Assets 16,041,200
Total Current Assets  (as reported)83,515,000
Total Current Assets  (calculated)69,658,100
+/- 13,856,900
Long-term Assets
Property Plant Equipment 47,874,900
Intangible Assets 74,900
Long-term Assets  (as reported)0
Long-term Assets  (calculated)47,949,800
+/- 47,949,800

Liabilities & Shareholders' Equity

Total Current Liabilities11,955,500
Long-term Liabilities-
Total Stockholder Equity117,281,800
Total Current Liabilities
Total Current Liabilities  (as reported)11,955,500
Total Current Liabilities  (calculated)0
+/- 11,955,500
Long-term Liabilities
Long term Debt Total 28,700
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)28,700
+/- 28,700
Total Stockholder Equity
Common Stock530,900
Retained Earnings 115,797,000
Capital Surplus 798,800
Other Stockholders Equity 155,100
Total Stockholder Equity (as reported)117,281,800
Total Stockholder Equity (calculated)117,281,800
+/-0
Other
Cash And Equivalents11,928,800
Cash and Short Term Investments 12,147,600
Common Stock Shares Outstanding 265,469
Liabilities and Stockholders Equity 133,747,100



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-31
> Total Assets 
37,104,917
44,113,786
49,021,154
61,585,300
67,858,500
80,382,500
85,357,000
107,740,700
133,747,100
133,747,100107,740,70085,357,00080,382,50067,858,50061,585,30049,021,15444,113,78637,104,917
   > Total Current Assets 
22,563,543
27,723,979
30,270,442
40,105,100
45,351,200
46,500,500
46,798,300
61,747,100
83,515,000
83,515,00061,747,10046,798,30046,500,50045,351,20040,105,10030,270,44227,723,97922,563,543
       Cash And Cash Equivalents 
405,057
176,211
179,496
787,024
251,500
130,000
200,100
218,000
218,800
218,800218,000200,100130,000251,500787,024179,496176,211405,057
       Short-term Investments 
5,018,762
7,330,036
0
16,307,220
18,892,800
13,983,400
9,823,600
0
0
009,823,60013,983,40018,892,80016,307,22007,330,0365,018,762
       Net Receivables 
7,298,139
7,508,699
8,901,353
9,009,200
10,143,600
11,633,700
14,133,500
16,765,200
24,238,800
24,238,80016,765,20014,133,50011,633,70010,143,6009,009,2008,901,3537,508,6997,298,139
       Inventory 
9,324,176
11,626,402
12,078,277
13,560,500
13,938,700
18,307,700
18,876,600
21,763,900
29,159,300
29,159,30021,763,90018,876,60018,307,70013,938,70013,560,50012,078,27711,626,4029,324,176
       Other Current Assets 
481,597
549,839
469,506
5,700
8,300
9,700
826,100
1,257,100
16,041,200
16,041,2001,257,100826,1009,7008,3005,700469,506549,839481,597
   > Long-term Assets 
0
0
0
21,480,190
22,480,300
33,882,000
38,558,700
0
0
0038,558,70033,882,00022,480,30021,480,190000
       Property Plant Equipment 
13,663,258
15,231,226
16,997,535
19,995,000
21,094,000
25,756,300
36,979,400
44,095,400
47,874,900
47,874,90044,095,40036,979,40025,756,30021,094,00019,995,00016,997,53515,231,22613,663,258
       Long Term Investments 
0
0
120
120
0
0
0
0
0
0000012012000
       Intangible Assets 
0
39,542
29,270
32,600
65,500
40,500
36,000
49,500
74,900
74,90049,50036,00040,50065,50032,60029,27039,5420
       Long-term Assets Other 
0
0
0
0
0
0
100
0
0
00100000000
> Total Liabilities 
7,471,420
9,160,188
6,088,071
8,011,400
8,610,500
10,811,000
12,257,800
14,794,600
16,465,300
16,465,30014,794,60012,257,80010,811,0008,610,5008,011,4006,088,0719,160,1887,471,420
   > Total Current Liabilities 
6,274,059
7,755,259
5,195,035
6,594,500
6,534,200
8,467,500
9,268,300
11,124,600
11,955,500
11,955,50011,124,6009,268,3008,467,5006,534,2006,594,5005,195,0357,755,2596,274,059
       Short-term Debt 
184,241
266,218
424,710
357,400
631,100
1,056,000
336,300
3,500
0
03,500336,3001,056,000631,100357,400424,710266,218184,241
       Short Long Term Debt 
184,241
266,218
424,710
357,385
631,100
1,056,000
336,300
0
0
00336,3001,056,000631,100357,385424,710266,218184,241
       Accounts payable 
1,517,048
2,268,657
2,326,905
3,838,573
4,112,100
4,922,600
5,907,200
0
0
005,907,2004,922,6004,112,1003,838,5732,326,9052,268,6571,517,048
       Other Current Liabilities 
3,817,364
4,361,348
695,309
566,662
645,600
743,200
1,128,200
0
0
001,128,200743,200645,600566,662695,3094,361,3483,817,364
   > Long-term Liabilities 
0
0
0
1,416,916
2,076,300
2,343,500
2,989,500
0
0
002,989,5002,343,5002,076,3001,416,916000
       Long term Debt Total 
0
0
0
0
0
0
44,700
36,900
28,700
28,70036,90044,700000000
       Capital Lease Obligations 
0
0
0
0
0
0
52,200
0
0
0052,200000000
> Total Stockholder Equity
29,633,497
34,953,598
42,933,083
53,573,900
59,248,000
69,571,500
73,099,200
92,946,100
117,281,800
117,281,80092,946,10073,099,20069,571,50059,248,00053,573,90042,933,08334,953,59829,633,497
   Common Stock
265,469
265,469
530,937
530,900
530,900
530,900
530,900
530,900
530,900
530,900530,900530,900530,900530,900530,900530,937265,469265,469
   Retained Earnings 
28,298,608
33,618,709
41,603,382
52,244,200
57,918,300
68,241,800
71,635,600
91,480,100
115,797,000
115,797,00091,480,10071,635,60068,241,80057,918,30052,244,20041,603,38233,618,70928,298,608
   Capital Surplus 
0
0
0
798,800
798,800
798,800
798,800
798,800
798,800
798,800798,800798,800798,800798,800798,800000
   Treasury Stock000000000
   Other Stockholders Equity 
5,187
5,187
0
0
92,300
78,300
133,900
136,300
155,100
155,100136,300133,90078,30092,300005,1875,187



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2022-03-31)

Gross Profit (+$)
totalRevenue89,598,300
Cost of Revenue-34,892,300
Gross Profit54,706,00054,706,000
 
Operating Income (+$)
Gross Profit54,706,000
Operating Expense--
Operating Income35,724,80054,706,000
 
Operating Expense (+$)
Research Development-
Selling General Administrative6,777,100
Selling And Marketing Expenses-
Operating Expense-6,777,100
 
Net Interest Income (+$)
Interest Income1,091,800
Interest Expense--
Net Interest Income-1,091,800
 
Pretax Income (+$)
Operating Income35,724,800
Net Interest Income-
Other Non-Operating Income Expenses-
Income Before Tax (EBT)36,835,00035,724,800
EBIT - interestExpense = 0
29,604,500
29,604,500
Interest Expense-
Earnings Before Interest and Taxes (ebit)-36,835,000
Earnings Before Interest and Taxes (ebitda)-
 
After tax Income (+$)
Income Before Tax36,835,000
Tax Provision-7,230,500
Net Income From Continuing Ops-29,604,500
Net Income29,604,500
Net Income Applicable To Common Shares29,604,500
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-0
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
NGU24-NYM.COMM
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of NGU24-NYM.COMM.

NGU24-NYM.COMM Daily Candlestick Chart
NGM24-NYM.COMM
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of NGM24-NYM.COMM.

NGM24-NYM.COMM Daily Candlestick Chart
NGQ24-NYM.COMM
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of NGQ24-NYM.COMM.

NGQ24-NYM.COMM Daily Candlestick Chart
ISKJ.MCX
5 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ISKJ.MCX.

ISKJ.MCX Daily Candlestick Chart
CHKZ.MCX
5 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CHKZ.MCX.

CHKZ.MCX Daily Candlestick Chart
VSYD.MCX
5 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of VSYD.MCX.

VSYD.MCX Daily Candlestick Chart
VRSB.MCX
5 hours ago

I found you a Golden Cross on the daily chart of VRSB.MCX.

VRSB.MCX Daily Candlestick Chart
TBRU.MCX
5 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of TBRU.MCX.

TBRU.MCX Daily Candlestick Chart
SNGSP.MCX
5 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SNGSP.MCX.

SNGSP.MCX Daily Candlestick Chart
RBCM.MCX
5 hours ago

I found you a Golden Cross on the daily chart of RBCM.MCX.

RBCM.MCX Daily Candlestick Chart
OKEY.MCX
5 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of OKEY.MCX.

OKEY.MCX Daily Candlestick Chart
MTLR.MCX
5 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of MTLR.MCX.

MTLR.MCX Daily Candlestick Chart
MRKZ.MCX
5 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of MRKZ.MCX.

MRKZ.MCX Daily Candlestick Chart
KRKN.MCX
5 hours ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of KRKN.MCX.

KRKN.MCX Daily Candlestick Chart
JNOS.MCX
5 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of JNOS.MCX.

JNOS.MCX Daily Candlestick Chart
BLNG.MCX
5 hours ago

I found you a Golden Cross on the daily chart of BLNG.MCX.

BLNG.MCX Daily Candlestick Chart
ASSB.MCX
5 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ASSB.MCX.

ASSB.MCX Daily Candlestick Chart
CSYZ.MU
5 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CSYZ.MU.

CSYZ.MU Daily Candlestick Chart
MOH.MU
5 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of MOH.MU.

MOH.MU Daily Candlestick Chart
TBK.V
5 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of TBK.V.

TBK.V Daily Candlestick Chart
UMDK.F
5 hours ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of UMDK.F.

UMDK.F Daily Candlestick Chart
RY4C.BE
5 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of RY4C.BE.

RY4C.BE Daily Candlestick Chart
PLY.BE
5 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of PLY.BE.

PLY.BE Daily Candlestick Chart
PDL.LSE
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of PDL.LSE.

PDL.LSE Daily Candlestick Chart
27F0.MU
5 hours ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of 27F0.MU.

27F0.MU Daily Candlestick Chart